agilon health (AGL) to Release Quarterly Earnings on Tuesday

agilon health (NYSE:AGLGet Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of ($0.01) per share for the quarter. agilon health has set its FY 2024 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.

agilon health (NYSE:AGLGet Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.13). agilon health had a negative net margin of 5.76% and a negative return on equity of 21.74%. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter in the prior year, the business posted ($0.14) earnings per share. agilon health’s revenue for the quarter was up 71.8% on a year-over-year basis. On average, analysts expect agilon health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

agilon health Price Performance

NYSE AGL opened at $4.83 on Monday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.51 and a current ratio of 1.51. The firm’s 50 day moving average price is $5.41 and its 200-day moving average price is $8.89. agilon health has a 52-week low of $4.41 and a 52-week high of $26.75. The company has a market cap of $1.99 billion, a PE ratio of -7.43 and a beta of 0.52.

Analysts Set New Price Targets

AGL has been the topic of a number of recent research reports. Leerink Partnrs downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, January 8th. TD Cowen downgraded shares of agilon health from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $12.00 to $6.50 in a research note on Monday, February 26th. Evercore ISI lowered their target price on shares of agilon health from $7.00 to $6.00 and set an “in-line” rating for the company in a research note on Wednesday, February 28th. Benchmark lowered their target price on shares of agilon health from $13.00 to $9.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Finally, Citigroup assumed coverage on shares of agilon health in a research note on Monday, April 22nd. They issued a “neutral” rating and a $6.00 target price for the company. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and four have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $9.32.

Check Out Our Latest Stock Report on agilon health

About agilon health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Earnings History for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.